UCB, announced data which showed that the addition of Cimzia® (certolizumab pegol) to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients. Company also claims that, consistent efficacy was observed across patients taking certolizumab pegol whether they had previously received TNF inhibitors or not and whether they received certolizumab pegol monotherapy or with concomitant DMARDs.....
Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label Certolizumab pegol. Show all posts
Showing posts with label Certolizumab pegol. Show all posts
Subscribe to:
Posts (Atom)